A carrier-free supramolecular nano-twin-drug for overcoming irinotecan-resistance and enhancing efficacy against colorectal cancer.
Yuan M, Chen T, Jin L, Zhang P, Xie L, Zhou S, Fan L, Wang L, Zhang C, Tang N, Guo L, Xie C, Duo Y, Li L, Shi L.
Yuan M, et al. Among authors: zhang c, zhang p.
J Nanobiotechnology. 2023 Oct 28;21(1):393. doi: 10.1186/s12951-023-02157-x.
J Nanobiotechnology. 2023.
PMID: 37898773
Free PMC article.